-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Piper Sandler Adjusts Century Therapeutics Price Target to $14 From $24, Maintains Overweight Rating

Piper Sandler Adjusts Century Therapeutics Price Target to $14 From $24, Maintains Overweight Rating

MT Newswires · 01/06/2023 04:47